Table 3.
type | neurological functions | mechanisms related to neurotransmission | PFAS neurotoxicity | source |
---|---|---|---|---|
Calcium Channel Group: High Voltage-Gated | ||||
L-type “long-lasting” | 42, 50–52 | |||
all subtypes (Cav1.2, Cav1.3, and Cav.1.,4) | tonic and slow release of neurotransmitters | subtypes have not been evaluated individually | ||
CaM/CaMK/CREB transcription-signaling and CaM/Fas/MAPK-signaling inhibits nicotinic signaling to CREB | PFOS and PFOA induce effects on calcium currents and enhance neurotransmission | |||
studies did not demonstrate complete block of all other calcium channels in the neuronal cells (effect may not be specific to L-type calcium channels) | ||||
studies have demonstrated that PFOS has downstream effects on the CaM/CaMKII/CREB signaling pathway including deficits in neuronal process formation | ||||
Cav1.2 | regulates working memory, social behavior, and adaptation to novel situations | in cortex and cerebellum: Cavl.2 C-terminus (CCAT) translocates and acts as a transcription factor for NMDA subunits, K+ channel subunits, and gap junction proteins; promotes neurite outgrowth | ||
in hippocampus: essential for spatial learning and memory. | expression in increased by cocaine exposure | |||
loss of function associated with psychiatric disorders including depression, bipol | induces calcium influx that drives the release of catecholamines | |||
required for neuronal circuit formation and amyglala functional disorder, and schizophrenia | ||||
Cav1.3 | in VTA and nucleus accumbens: involved with cocaine-induced chronic behavioral changes | expression is decreased with cocaine exposure | ||
increased expression in early stage Parkinson’s disease | in hippocampus: better coupling to CREB compared to Cav1.2 | |||
channel blocker is a potential target for Parkinson’s disease treatment | in striatal spiny neurons: the only channel that couples to CREB | |||
induces calcium influx that drives the release of catecholamines in substantia nigra dopaminergic neurons: expression and regulation of pacemaking increases with age | ||||
Calcium Channel Group: High Voltage-Gated | ||||
N-type “neural” | needs evaluation | |||
Cav2.2 | regulates working memory, social behavior, and adaptation to novel situations | rapid synaptic neurotransmitter release | ||
loss of function reduces ethanol consumption and increases activity | involved in GABA release in some cells in the hippocampus | |||
primary channel for synaptic glutamate release in many brain regions in hippocampus: partial functional compensation when Cav2.1 has lost function | ||||
Calcium Channel Group: High Voltage-Gated | ||||
P-type/Q-type | needs evaluation | |||
“Purkinje”/“Q after P” Cav2.1 | hippocampus: loss of function induces seizures | rapid synaptic neurotransmitter release | ||
cerebellum: loss of function induces ataxia and seizures | primary channel for synaptic glutamate release in many brain regions | |||
gain-of-function mutation induces migraines and cortical depression | involved in GABA release of interneurons in the cortex, pyramidal neurons, and many other neurons | |||
Calcium Channel Group: High Voltage-Gated | ||||
R-type “residual” | needs evaluation | |||
Cav2.3 | loss of function decreases pain sensitivity | rapid synaptic neurotransmitter release | ||
in hippocampus: partial functional compensation when the Cav2.1 function is lost Calcium Channel Group: Low Voltage-Gated | ||||
Calcium Channel Group: Low Voltage-Gated | ||||
T-type “transient” Cav3.1, Cav3.2, and Cav3.3 | involved in regulating sleep patterns and arousal | drives low-threshold exocytosis of neurotransmitters | needs evaluation | |
mutations associated with epilepsy and autism spectrum disorders | key role in regulating the thalmocortical circuit | |||
induces calcium influx that drives the release of catecholamines | ||||
Calcium Channel Group: Ionotropic Glutamate Receptor | ||||
AMPA receptor | synaptic plasticity, long-term potentiation, and action potentials | glutamate-dependent activation of the calcium channel | PFOS decreases subunit expression, thus allowing the AMPA-R type that is permeable to calcium | 40–42, 49, 90 |
calcium or sodium permeability is determined by the GluA2 subunit; AMPA-R allows calcium to penetrate without the GluA2 subunit or if the GluA2 subunit is the unedited GluA2(Q) isomer; the edited GluA2(R) isomer is normally expressed in neurons | PFOS increases intracellular calcium through the AMPA-R | |||
expression of edited and nonedited GluA2 receptors after PFAS exposure needs evaluation | ||||
NMDA receptor | synaptic plasticity, long-term potentiation, and action potentials | produces excitoxicity-induced cell death by C/EBPβ transcriptional activity | PFOS increases intracellular calcium through glutamateactivated NMDA-R, inducing excitotoxicity | 38, 39, 41, 43, 54 |
glutamate-dependent activation of the calcium channel | PFOS can increase excitoxicity through the NMDA-R using glutamate-independent toxicity, through an unknown mechanism | |||
inhibited by L-type induced CREB signaling NMDA-induced increases in calcium activate CaMKIIa |
Neurological functions of voltage-gated calcium channels are summarized from reviews by Dolphin and Lee (2020),95 Saravanaraman et al. (2014),91 Simms and Zamponi (2014),96 and Wang and Jin (2012).53 The calcium channels that are primarily linked to PFAS neurotoxicity are the L-type high-voltage gated channels and the NMDA and AMPA glutamate receptors. Nearly all studies on the toxic effects of PFAS exposure on these calcium channels have only tested PFOS and PFOA.38–43,50–52,54 There is much to be learned regarding the roles of calcium channels as primary neurotoxic targets. The primary goal of this table is to prompt mechanistic research.